Form 4: Phathom Pharmaceuticals Director Asit Parikh Increases Stake in Company

Director Asit Parikh of Phathom Pharmaceuticals, Inc. reports purchasing 10,000 shares of common stock in two transactions.

Summary

• Asit Parikh, a director at Phathom Pharmaceuticals, Inc., has reported changes in their beneficial ownership of the company's stock.
• On May 6, 2025, Parikh purchased 5,000 shares of common stock at a price of $2.6 per share, increasing their holdings to 90,500 shares.
• On May 7, 2025, Parikh purchased another 5,000 shares of common stock at $2.3969 per share, bringing their total ownership to 95,500 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects insider buying, which can be seen as a positive signal, but it's a relatively small transaction and doesn't provide definitive insight into the company's overall health.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common in the pharmaceutical industry. Monitoring insider transactions can provide insights into management's sentiment about the company's prospects.

Stakeholder Impact

• The increased stake of a director may increase shareholder confidence.

Key Dates

Keywords

Phathom Pharmaceuticals, PHAT, Asit Parikh, Stock Purchase, Beneficial Ownership, Director, Form 4